Subtopic Deep Dive
PCR Diagnosis of Tuberculous Peritonitis
Research Guide
What is PCR Diagnosis of Tuberculous Peritonitis?
PCR Diagnosis of Tuberculous Peritonitis uses polymerase chain reaction assays on ascitic fluid to detect Mycobacterium tuberculosis DNA for rapid confirmation of peritoneal tuberculosis.
Studies assess GeneXpert MTB/RIF and multi-target PCR for diagnosing tuberculous peritonitis in high-burden settings with paucibacillary effusions. Tortoli et al. (2012) validated Xpert MTB/RIF for extrapulmonary TB, including peritoneal sites, reporting pooled sensitivity of 67% across EPTB specimens (319 citations). Mehta et al. (2012) reviewed PCR methods for EPTB diagnosis, highlighting challenges in low-bacterial-load fluids (188 citations).
Why It Matters
Prompt PCR-based diagnosis enables early anti-TB therapy, reducing complications like bowel obstruction in tuberculous peritonitis. Kohli et al. (2018) showed Xpert MTB/RIF sensitivity of 25-85% in peritoneal fluid, aiding rifampicin resistance detection for personalized care (216 citations). In high-burden areas, this shortens diagnostic delay from weeks to hours, improving outcomes in HIV-co-infected patients as noted by Tortoli et al. (2012). Weyer et al. (2012) emphasized global policy shifts toward Xpert implementation for EPTB (258 citations).
Key Research Challenges
Low Sensitivity in Paucibacillary Effusions
Peritoneal fluid often has low bacterial load, reducing PCR detection rates to 25-50%. Kohli et al. (2018) reported 25% sensitivity for ascitic fluid versus 85% for lymph nodes. Optimization of DNA extraction remains critical (216 citations).
Rifampicin Resistance Detection Limits
Xpert MTB/RIF misses some resistant strains in EPTB. Dookie et al. (2018) detailed molecular determinants, noting sequencing needs beyond probe-based detection. Validation in peritonitis-specific cohorts is limited (332 citations).
HIV Co-infection Diagnostic Interference
Immunosuppression lowers bacillary load, complicating PCR results. Mehta et al. (2012) observed reduced PCR yield in HIV-associated EPTB. Combined biomarkers may improve accuracy (188 citations).
Essential Papers
Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care
Navisha Dookie, Santhuri Rambaran, Nesri Padayatchi et al. · 2018 · Journal of Antimicrobial Chemotherapy · 332 citations
Drug-resistant TB (DR-TB) remains a significant challenge in TB treatment and control programmes worldwide. Advances in sequencing technology have significantly increased our understanding of the m...
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Enrico Tortoli, Cristina Russo, Claudio Piersimoni et al. · 2012 · European Respiratory Journal · 319 citations
Extrapulmonary tuberculosis (EPTB) accounts for more than 20% of tuberculosis (TB) cases. Xpert MTB/RIF (Xpert) (Cepheid, Sunnyvale, CA, USA) is a fully automated amplification system, for which ex...
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
Karin Weyer, Fuad Mirzayev, Giovanni Battista Migliori et al. · 2012 · European Respiratory Journal · 258 citations
If tuberculosis (TB) is to be eliminated as a global health problem in the foreseeable future, improved detection of patients, earlier diagnosis and timely identification of rifampicin resistance w...
Xpert<sup>®</sup>MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Mikashmi Kohli, Ian Schiller, Nandini Dendukuri et al. · 2018 · Cochrane Database of Systematic Reviews · 216 citations
In people presumed to have extrapulmonary TB, Xpert may be helpful in confirming the diagnosis. Xpert sensitivity varies across different extrapulmonary specimens, while for most specimens, specifi...
Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
Mikashmi Kohli, Ian Schiller, Nandini Dendukuri et al. · 2021 · Cochrane Database of Systematic Reviews · 199 citations
Xpert Ultra and Xpert MTB/RIF may be helpful in diagnosing extrapulmonary tuberculosis. Sensitivity varies across different extrapulmonary specimens: while for most specimens specificity is high, t...
Diagnosis of extrapulmonary tuberculosis by PCR
Promod K. Mehta, Ankush Raj, Netrapal Singh et al. · 2012 · FEMS Immunology & Medical Microbiology · 188 citations
During the last two decades, the resurgence of tuberculosis (TB) has been documented in both developed and developing nations, and much of this increase in TB burden coincided with human immunodefi...
Tuberculosis Biomarkers: From Diagnosis to Protection
Delia Goletti, Elisa Petruccioli, Simone A. Joosten et al. · 2016 · Infectious Disease Reports · 170 citations
New approaches to control tuberculosis (TB) worldwide are needed. In particular, new tools for diagnosis and new biomarkers are required to evaluate both pathogen and host key elements of the respo...
Reading Guide
Foundational Papers
Start with Tortoli et al. (2012, 319 citations) for Xpert EPTB validation and Mehta et al. (2012, 188 citations) for PCR principles in extrapulmonary sites.
Recent Advances
Kohli et al. (2018, 216 citations) on Xpert for EPTB/RIF resistance; Kohli et al. (2021, 199 citations) comparing Ultra vs. MTB/RIF in adults.
Core Methods
Automated cartridge-based amplification (Xpert MTB/RIF/Ultra) and conventional multi-target PCR on ascitic fluid, with IS6110 and rpoB targets (Mehta et al. 2012).
How PapersFlow Helps You Research PCR Diagnosis of Tuberculous Peritonitis
Discover & Search
PapersFlow's Research Agent uses searchPapers and exaSearch to find studies on PCR in tuberculous peritonitis, such as Tortoli et al. (2012), then citationGraph reveals 319 citing papers on EPTB diagnostics. findSimilarPapers expands to peritoneal fluid-specific GeneXpert validations.
Analyze & Verify
Analysis Agent applies readPaperContent to extract sensitivity data from Kohli et al. (2018), verifies meta-analysis claims via verifyResponse (CoVe), and runs PythonAnalysis for pooling sensitivities across 10 EPTB studies with GRADE grading for evidence quality.
Synthesize & Write
Synthesis Agent detects gaps like peritonitis-specific Ultra assays post-2021, flags contradictions in sensitivity reports, and uses latexEditText with latexSyncCitations for drafting reviews. Writing Agent compiles LaTeX manuscripts with latexCompile and exportMermaid for diagnostic workflow diagrams.
Use Cases
"What is the pooled sensitivity of Xpert MTB/RIF on ascitic fluid for tuberculous peritonitis?"
Research Agent → searchPapers('Xpert MTB/RIF ascitic fluid peritonitis') → Analysis Agent → readPaperContent(Kohli 2018) → runPythonAnalysis(pandas meta-analysis pooling) → GRADE-graded sensitivity report with 95% CI.
"Draft a LaTeX review section on PCR challenges in TB peritonitis."
Synthesis Agent → gap detection(Tortoli 2012, Mehta 2012) → Writing Agent → latexEditText('PCR sensitivity paucibacillary') → latexSyncCitations(5 papers) → latexCompile → PDF section with peritoneal diagnostic flowchart.
"Find open-source code for MTB PCR primer design analysis."
Research Agent → paperExtractUrls(Mehta 2012) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python sandbox verification of primer specificity scripts.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ EPTB papers: searchPapers → citationGraph(Tortoli 2012) → DeepScan 7-step analysis with CoVe checkpoints → structured report on peritonitis PCR evolution. Theorizer generates hypotheses on multi-target PCR improvements from Dookie et al. (2018) resistance data. DeepScan verifies GeneXpert Ultra upgrades (Kohli 2021) via runPythonAnalysis on meta-analytic datasets.
Frequently Asked Questions
What defines PCR diagnosis of tuberculous peritonitis?
PCR targets Mycobacterium tuberculosis DNA in ascitic fluid for rapid EPTB confirmation, as validated by Tortoli et al. (2012) for Xpert MTB/RIF.
What are main PCR methods used?
GeneXpert MTB/RIF and multi-target PCR; Kohli et al. (2018) pooled sensitivities across EPTB sites including peritoneum (216 citations).
What are key papers?
Tortoli et al. (2012, 319 citations) on Xpert validation; Mehta et al. (2012, 188 citations) on EPTB PCR; Kohli et al. (2018, 216 citations) on extrapulmonary applications.
What open problems exist?
Improving sensitivity in paucibacillary ascites and rifampin resistance genotyping in peritonitis, per Dookie et al. (2018).
Research Diagnosis and treatment of tuberculosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching PCR Diagnosis of Tuberculous Peritonitis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers